ClinicalTrials.gg
CompletedNCT05272085Updated Jan 31, 2023

Comparison of the Efficiency of Ultrasound-Guided Lavage and Subacromial Bursa Injection in Calcific Tendinitis

An interventional study of Ultrasound Guided Lavage and Ultrasound Guided Subacromial Bursa Injection in Calcific Tendinitis, Calcific Tendinitis of Shoulder and Shoulder Pain, sponsored by Istanbul University - Cerrahpasa. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-01-31.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

It is aimed to compare in the early period the clinical and ultrasonographic findings in terms of the effectiveness of ultrasound-guided subacromial bursa injection with corticosteroid and ultrasound-guided lavage, which are the treatment options available in the literature for patients with calcific tendinitis who do not respond to conservative treatment.

Read the detailed description

Calcific tendinitis is a disease that occurs with the precipitation of hydroxyapatite crystals on tendons and shoulder region is the most involved. In the shoulder region, calcific tendinitis can involve all rotator cuff tendons, most commonly the supraspinatus. It may progress with pain and functional limitation. The pain can increase with movement or can occur at rest and sleep. The prevalence of calcific tendinitis is between 2.7% and 20% in the general population. The most common age group is between 30 and 60. It can negatively affect the family and social life of the person and cause loss of workforce.

Especially in the treatment of patients with calcific tendinitis unresponsive to conservative treatment, ultrasound-guided corticosteroid injection in subacromial bursa and ultrasound-guided lavage are frequently used treatment options. However, there are very few studies in the literature comparing these two treatment methods as randomized controlled trials.

In this study, it is aimed to compare the effectiveness of ultrasound guided subacromial bursa injection and ultrasound guided lavage procedures on pain scores, functional scales, disability scales, direct radiography findings and ultrasonographic imaging findings.

02

Conditions studied

  • Calcific Tendinitis
  • Calcific Tendinitis of Shoulder
  • Shoulder Pain

Keywords

  • Calcific tendinitis
  • Shoulder pain
  • Ultrasound-guided
  • Lavage
  • Barbotage
  • subacromial bursa injection
03

In context

Rotator Cuff Tear Arthropathy

55 studies on the registry are indexed under Rotator Cuff Tear Arthropathy; 14 are open to participants now.

This study's enrollment of 32 is below the median of 93 across 31 interventional studies indexed under Rotator Cuff Tear Arthropathy.

Browse Rotator Cuff Tear Arthropathy studies →

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 693 studies on the registry; 213 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cases diagnosed with calcific tendinitis who did not benefit from conservative treatment
  • Cases with calcific deposits greater than 1 cm in direct radiography, ultrasonography, or magnetic resonance imaging
  • Cases between the ages of 18-75 whose informed consent was obtained for participation in the study

Exclusion criteria

Exclusion Criteria:

  • Cases with radiculopathy ipsilateral to the affected shoulder
  • Cases with active inflammatory arthropathy of the affected shoulder
  • Cases with previous shoulder surgery
  • Cases with a history of humeral head, scapula, and clavicle fractures
  • Cases with neurological deficit affecting the upper extremity
  • Cases with uncontrolled diabetes mellitus and uncontrolled hypertension, uncompensated congestive heart failure, chronic renal failure, chronic liver disease, tumor and/or vascular disease, inflammatory and/or infectious diseases, currently active psychiatric disease
  • Cases with a history of subacromial bursa injection, calcific lavage or shoulder joint injection in the last 3 months
  • Cases with a history of allergic reaction to the substance to be applied as local anesthetic
  • Pregnancy or lactation
  • Anticoagulant or antiagregant (antiplatelet) medication use that may interfere with the injection procedure.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Ultrasound Guided Lavage Group

    The physical examination, pain scoring, functional scale, disability scale, special tests, direct radiography findings and ultrasonographic imaging findings of the patients in this group before the treatment and 1 month after the treatment will be evaluated and will be recorded. Size of calcific deposits and Gartner classification will be evaluated on direct radiography. Size, shape, acoustic shadowing, power doppler activity of calcific deposits and other bursitis, tendinitis, ruptures, effusion in the shoulder will be evaluated on ultrasonographic imaging. Patients in this group will be treated with ultrasound-guided lavage.

    Procedure: Ultrasound Guided Lavage

  • Active comparator
    Ultrasound Guided Subacromial Bursa Injection Group

    The physical examination, pain scoring, functional scale, disability scale, special tests, direct radiography findings and ultrasonographic imaging findings of the patients in this group before the treatment and 1 month after the treatment will be evaluated and will be recorded. Size of calcific deposits and Gartner classification will be evaluated on direct radiography. Size, shape, acoustic shadowing, power doppler activity of calcific deposits and other bursitis, tendinitis, ruptures, effusion in the shoulder will be evaluated on ultrasonographic imaging. Patients in this group will be treated with ultrasound-guided subacromial bursa injection with corticosteroid and lidocaine.

    Procedure: Ultrasound Guided Subacromial Bursa Injection

Interventions

  • ProcedureUltrasound Guided Lavage

    After local anesthesia of subcutaneous tissue, lavage will be performed under the guidance of ultrasound using an 18-gauge needle with injectors filled with 4 ml of saline. The needle will be advanced to the center of the calcific deposit. The injector will be kept as parallel to the ground as possible. The plunger of the injector will be pushed with a gently pressure and then released. Calcific deposits are expected to be filled into the syringe along with saline. It is predicted that the clear saline will gradually turn white and become cloudy due to the incoming calcific deposits. When the color of the liquid becomes cloudy, the syringe will be removed without moving the needle, and a new syringe containing 4 ml saline will be placed in its place. Thus, the aspirated calcific deposits will not be reinjected. The same process will be repeated with a new saline filled syringe. After the procedure, 2 ml dexamethasone and 3 ml lidocaine will be injected in subacromial bursa.

    Also known as: Ultrasound Guided Barbotage

  • ProcedureUltrasound Guided Subacromial Bursa Injection

    2 ml dexamethasone and 3 ml %2 lidocaine will be injected in the subacromial bursa using a 21-gauge needle under ultrasound guidance.

06

What researchers measure

Primary outcomes

  1. Change of Range of Motion

    The change in a participant's range of motion degree as measured by a goniometer (Passive Range of Motion and Active Range of Motion) from baseline to 1 month.

    Time frame: Baseline, 1 month

  2. Clinical improvement measured by change in Numeric Rating Scale

    A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. A patient selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing "worst possible pain"

    Time frame: Baseline, 1 hour, 1 month

  3. Clinical improvement measured by change in Constant Shoulder Score

    The constant shoulder score is a validated scale, measuring the shoulder function. It is an objective measurement independent of the shoulder pain. It is a 100-points scale composed of a number of individual parameters. The minimum score is 0, the maximum score is 100 points. The higher the score, the higher the quality of the function.

    Time frame: Baseline, 1 month

  4. Clinical improvement measured by change in Quick Dash Score

    Individual's ability to complete tasks, absorb forces, and severity of symptoms are measured by a 11 item Quick Dash questionnaire. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability).

    Time frame: Baseline, 1 month

  5. Clinical improvement measured by change in Shoulder Disability Questionnaire

    This score measures the disability of the shoulder in daily life, work, social life.0 points indicate maximum well-being, 100 points indicate maximum disability

    Time frame: Baseline, 1 month

  6. Change in Gartner Score of the Shoulder Calcifications on Direct Radiography

    Radiological classification of calcifying tendinitis

    Time frame: Baseline, 1 month

  7. Change in ultrasound scoring system presented by Chiou

    This score includes size, shape (arc, fragmented, nodular, cystic), power doppler activity of calcific deposits.

    Time frame: Baseline, 1 month

  8. Change in ultrasound classification system of calcific deposits presented by Farin

    This classification includes acoustic shadowing of calcific deposits (well-defined shadow, faint shadow and no shadow)

    Time frame: Baseline, 1 month

07

Study locations

1 site
  • Istanbul University- Cerrahpaşa
    Istanbul, 34098, Turkey (Türkiye)
08

References and documents

Publications

  • Louwerens JK, Sierevelt IN, van Hove RP, van den Bekerom MP, van Noort A. Prevalence of calcific deposits within the rotator cuff tendons in adults with and without subacromial pain syndrome: clinical and radiologic analysis of 1219 patients. J Shoulder Elbow Surg. 2015 Oct;24(10):1588-93. doi: 10.1016/j.jse.2015.02.024. Epub 2015 Apr 11. PubMed 25870115 ↗
  • Sansone V, Maiorano E, Galluzzo A, Pascale V. Calcific tendinopathy of the shoulder: clinical perspectives into the mechanisms, pathogenesis, and treatment. Orthop Res Rev. 2018 Oct 3;10:63-72. doi: 10.2147/ORR.S138225. eCollection 2018. PubMed 30774461 ↗
  • Sansone V, Consonni O, Maiorano E, Meroni R, Goddi A. Calcific tendinopathy of the rotator cuff: the correlation between pain and imaging features in symptomatic and asymptomatic female shoulders. Skeletal Radiol. 2016 Jan;45(1):49-55. doi: 10.1007/s00256-015-2240-3. Epub 2015 Aug 27. PubMed 26306389 ↗
  • Greis AC, Derrington SM, McAuliffe M. Evaluation and nonsurgical management of rotator cuff calcific tendinopathy. Orthop Clin North Am. 2015 Apr;46(2):293-302. doi: 10.1016/j.ocl.2014.11.011. Epub 2015 Jan 27. PubMed 25771323 ↗
  • de Witte PB, Selten JW, Navas A, Nagels J, Visser CP, Nelissen RG, Reijnierse M. Calcific tendinitis of the rotator cuff: a randomized controlled trial of ultrasound-guided needling and lavage versus subacromial corticosteroids. Am J Sports Med. 2013 Jul;41(7):1665-73. doi: 10.1177/0363546513487066. Epub 2013 May 21. PubMed 23696211 ↗
  • Chiou HJ, Chou YH, Wu JJ, Hsu CC, Huang DY, Chang CY. Evaluation of calcific tendonitis of the rotator cuff: role of color Doppler ultrasonography. J Ultrasound Med. 2002 Mar;21(3):289-95; quiz 296-7. doi: 10.7863/jum.2002.21.3.289. PubMed 11883540 ↗
  • Farin PU, Jaroma H. Sonographic findings of rotator cuff calcifications. J Ultrasound Med. 1995 Jan;14(1):7-14. doi: 10.7863/jum.1995.14.1.7. PubMed 7707483 ↗
  • Gartner J, Heyer A. [Calcific tendinitis of the shoulder]. Orthopade. 1995 Jun;24(3):284-302. German. PubMed 7617385 ↗
  • Zhang T, Duan Y, Chen J, Chen X. Efficacy of ultrasound-guided percutaneous lavage for rotator cuff calcific tendinopathy: A systematic review and meta-analysis. Medicine (Baltimore). 2019 May;98(21):e15552. doi: 10.1097/MD.0000000000015552. PubMed 31124934 ↗
  • Lee S.H. (2020) Calcific Tendinitis Intervention. In: Peng P., Finlayson R., Lee S., Bhatia A. (eds) Ultrasound for Interventional Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-030-18371-4_26

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05272085
Responsible party
Nuri Tugbay Yildiran (Principal Investigator, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Mar 9, 2022
Start date
Mar 9, 2022
Primary completion
Aug 30, 2022
Completion
Nov 30, 2022
Last update
Jan 31, 2023

Study contacts

NURI TUGBAY YILDIRAN
principal investigator · Istanbul University - Cerrahpasa
DENIZ PALAMAR
study director · Istanbul University - Cerrahpasa
BILGE CAKIR
study chair · Istanbul University - Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion